Ezrin表达与可能源于祖细胞的肝细胞癌及术后早期复发的病例相关(英)

肝细胞癌的不同生物学特征可能归因于肝癌细胞的起源.对于可能起源肝祖细胞的肝细胞癌患者在外科手术切除术或肝移植术后存在肿瘤早期复发,预示这些肿瘤具有侵袭性特征.

肝癌手术切除后肝断面处理分析

肝癌手术创面的处理目前临床上以两种方式比较普遍,一种是创面对拢缝合技术;一种是创面敞开,可再加用生物胶喷洒及止血材料贴敷.为探讨两种肝断面处理技术对肝癌手术有何影响,作者对东南大学附属盐城医院2001～2008年间85例获得手术切除肝癌病例的手术资料进行回顾分析,报告如下.

Recurrent ameloblastoma is common following inadequate excision but rarely presents in the anterior skull base. We presented 3 patients with recurrent ameloblastoma in the anterior skull base including the frontotemporal fossa and the pterygomaxillary fossa that occurred following multiple enucleations, segmental mandibulectomy, or partial maxillectomy for ameloblastoma in the jaws. Attenborough approach was used in the exposure of the frontotemporal fossa. Attenborough plus Barbosa approach was used in the exposure of the pterygomaxillary fossa. The patients were treated by radical dissection. Microscopy confirmed that the histopathologic pattern of one case was fixed follicular and plexiform, two cases were follicular. All patients healed without serious complications. The local recurrences of the patients following the operations were found in 3 to 4 years. The present study showed that the tumors in the regions had a greater recurrence potential even when treated with radical dissection, and the original tumors were the high-risk follicular pattern.

Kasabach-Merritt综合征12例报告

Kasabach-Merritt综合征译称为血管瘤伴发血小板减少综合症,是婴儿血管瘤的少见合并症.自1940年首例报道以来,国外文献已有数10例记载(1).

食管癌的治疗进展

Introduction Management of esophageal cancer has seen much progress in the past two decades. There used to be only three treatment options for patients suffering this deadly disease: surgical resection, external irradiation therapy, and intubation with plastic prosthesis. For those with terminal disease, a gastrostomy tube was often inserted. This was an unsatisfactory procedure for it merely prolonged life without meaningful palliation. In recent years, surgical resection has been refined, techniques of radiation improved, neoadjuvant or adjuvant therapies with chemotherapy and/or radiotherapy added, and various new methods of endoscopic procedures made available for palliation. For each patient, the best single or combination of treatments has to be individualized. Therapeutic options for esophageal cancer have indeed increased. There are three main areas in which progress is most evident: they are surgical resection, multimodality treatment, and endoscopic palliation.